She serves on several expert panels including for the UK HD association, the European HD Network, NINDS/NIH, and the MRC Nucleic Acid Therapies Accelerator Board. Sarah has published over350 peer-reviewed publications to date and her research work has been the subject of articles in NEJM, The Economist, Scientific American, and The Lancet. In addition to basic bench science, which focuses on basic cellular mechanisms of neurodegeneration in Huntington’s disease (HD), she also leads a large translational research programme in HD that is working towards finding effective disease-modifying treatments. Sarah is Director of the UCL Huntington’s Disease Centre, which she co-founded with Professor Gill Bates in 2016, and Joint Head of Department Neurodegenerative Disease at the UCL Queen Square Institute of Neurology. She was promoted to Senior Lecturer and Honorary Consultant Neurologist in 2003, and to Full Professor in 2009.
After clinical training, she obtained a DH National Clinician Scientist Fellowship in 2002 to work on protein misfolding at UCL. She has worked on research into neurodegenerative diseases since her PhD as an MRC clinical training fellow at UCL. Sarah graduated with First class honours in biochemistry, then studied medicine at the University of Edinburgh in 1992 where she graduated with the Gold Medal for top student.
0 kommentar(er)
